InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（6 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
6
T+90 胜率
100%
T+90 平均收益
+16.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Lettmann Jason, 董事. Director active across 1 company, notably ALX Oncology Holdings INC. Cumulatively, 12 filings have been published. Split: 2 buys · 6 sells. Total volume traded: €1.4m. History available since 8 December 2021. The latest transaction was disclosed on 17 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lettmann Jason
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
2,230 股@ US$1.930.0016% mcap0.3% 占其流量Common StockSEC:0001193125-26-355764:0
12,311 股@ US$2.171.7% 占其流量Common StockSEC:0001193125-26-119705:0
2,201 股@ US$2.270.3% 占其流量Common StockSEC:0001193125-26-060037:0
21,070 股@ US$1.0661.3% 占其流量Common StockSEC:0001193125-25-207432:0
标准退出：2025年12月15日 (T+90)
2,382 股@ US$0.64040.0% 占其流量Common StockSEC:0000950170-25-110099:0
42,000 股0Common StockSEC:0001415889-25-008417:0
2,159 股@ US$1.15020.1% 占其流量Common StockSEC:0001415889-25-005067:0
2,191 股@ US$2.580.2% 占其流量Common StockSEC:0001415889-24-021471:0
4,400 股@ US$11.31171.7% 占其流量Common StockSEC:0001415889-24-008260:0
标准退出：2024年6月12日 (T+90)
60,000 股0Common StockSEC:0001415889-24-004210:0
11,945 股@ US$25.2918.8% 占其流量Common StockSEC:0000899243-21-048463:0
35,836 股@ US$33.2374.2% 占其流量Common StockSEC:0001209191-21-069154:0
12 条申报中的 12 条
About Lettmann Jason
Jason Lettmann is Administrateur and Chief Executive Officer at ALX Oncology Holdings INC, listed on XNAS. He has 11 filings, and across the 11 sampled filings from 2021-12-10 to 2026-03-23, the aggregated amounts show EUR 64351 of buys and EUR 1350072 of sells; the most common transaction nature is Sale.
